3-(.ALPHA.-ACETONYL-P-NITROBENZYL)-4-HYDROXYCOUMARIN
Aortic Valve Disease
St. Antonius HospitalSmall moleculePhase 4 / ApprovedDormant
BB
69/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 54/ 100
- Competitive Position
- 95/ 100
Competitive context
6 Active assets in the Aortic Valve Disease cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Acetylsalicylic Acid Assistance Publique - Hôpitaux de Paris | Phase 4 | BBB |
Plavix Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec | Phase 4 | BBB |
PHENPROCOUMON St. Antonius Hospital | Phase 4 | BB |
Dabigatran St. Antonius Hospital | Phase 4 | BB |
Apixaban Assistance Publique - Hôpitaux de Paris | Phase 3 | B |
View all 9 →
Same molecule, other indications
3-(.ALPHA.-ACETONYL-P-NITROBENZYL)-4-HYDROXYCOUMARIN is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →